2009

1. Langley, A., Fallon, G. R. and Kakabadse, N. K. (2009) Strategy evolution in Central and Eastern European pharmaceutical firms 1992-2005. Strategic Change. 18(1), pp. 59-80. 1086-1718.

2007

1. Langley, A., Fallon, G. R. and Kakabadse, N. K. (2007) Strategic responses to market developments in transition economies: evidence from CEE based pharmaceutical firms. Paper presented to: Academy of International Business (UK & Ireland Chapter) 34th Annual Conference, King's College London, 13-14 April 2007. London: Academy of International Business UK Chapter.
2. Langley, A., Kakabadse, N. K. and Swailes, S. (2007) Longitudinal textual analysis: an innovative method for analysing how realised strategies evolve. Qualitative Research in Organizations and Management: An International Journal. 2(2), pp. 104-125. 1746-5648.
3. Langley, A., Kakabadse, N. K. and Swailes, S. (2007) Strategy development in a transitional economy: the case of LEK. Strategic Change. 16(4), pp. 161-176. 1099-1697.
4. Langley, A., Kakabadse, N. K. and Swailes, S. (2007) Temporal patterns of strategy development and strategic action and coevolution: the pharmaceutical industry. Paper presented to: 14th International Conference on Multi-Organisational Partnerships, Alliances and Networks (MOPAN 2007), Leuven, Belgium, 28-29 June 2007. Leuven, Belgium: Katholieke Universiteit Leuven. (Unpublished)
5. Langley, A., Kakabadse, N. K. and Swailes, S. (2007) Evolutionary patterns of strategic change prior to liquidation: the case of Bioglan plc. Management Decision. 45(4), pp. 657-683. 0025-1747.
6. Langley, A., Kakabadse, N. K. and Swailes, S. (2007) Internationalisation strategies realised by incumbent firms as an industry evolves into global oligopoly: the case of the pharmaceutical industry. In: Sinkovics, R. R. and Yamin, M. (eds.) Anxieties and Management Responses in International Business. Basingstoke: Palgrave MacMillan. pp. 140-157.

2005

1. Langley, A. (2005) Strategic change in the pharmaceutical industry 1992-2002: evolution and coevolution of firms' grand strategies. Doctoral thesis. University of Leicester.
2. Langley, A., Kakabadse, N. K. and Swailes, S. (2005) Grand strategies and strategic actions in the pharmaceutical industry 2001-2002. Technology Analysis & Strategic Management. 17(4), pp. 519-534. 1465-3990.